Answers are grounded in this paper and cite their sources.
The rising prevalence of antimicrobial resistance has significantly diminished the effectiveness of conventional anti-infective therapies, emphasizing the need for alternative antibacterial strategies. Chirality serves as a critical determinant of biological activity at the molecular level; however, the mechanisms by which molecular configuration governs biomedical functions through supramolecular assembly remain inadequately understood. This study presents chirality-dependent antibacterial co-assemblies formed from berberine (BBR), a natural bioactive alkaloid, and enantiomeric histidine. The L-His/BBR and D-His/BBR co-assemblies demonstrated distinctly different antibacterial activities, with L-His/BBR exhibiting superior efficacy. Mechanistic investigations uncovered configuration-dependent perturbations in bacterial metabolism: D-His/BBR primarily influenced amino acid metabolism, particularly regarding branched-chain amino acids and arginine, while L-His/BBR prompted more significant alterations in purine nucleotide metabolism. Additionally, L-His/BBR more effectively suppressed the expression of virulence-associated genes compared to its D-configured counterpart, further enhancing its antibacterial activity. In vitro anti-inflammatory assays and in vivo infection models confirmed the superior therapeutic performance of L-His/BBR. Collectively, these findings establish a definitive connection between molecular configuration, supramolecular chirality, and biological function, highlighting chirality’s role as a strategic design parameter in the development of supramolecular antibacterial materials from natural bioactive components.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: